ArticleJournal of animal science and technology2025
Protective effects of enzymatically digested velvet antler polypeptides on mitochondria in primary astrocytes.
Article in Journal of animal science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Efficacy and Safety of Enzyme-Derived Deer Velvet Extract Supplementation on Adults with Chronic Fatigue: a Randomized, Placebo-Controlled, Double-Blind Trial.Journal of microbiology and biotechnology · 2026Trial
- Protective Effects ofJournal of microbiology and biotechnology · 2026Article
- Deer antler velvet as a multifunctional natural resource for biomedical and nutraceutical applications.Food science of animal resources · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditionally, velvet antler (VA) has been used as a medicine or dietary supplement in East Asia. It contains biologically active compounds that exert anti-inflammatory, anti-fatigue, anti-aging, and anticancer effects. Although demand for VA has increased globally, its supply and consumption are limited due to the low recovery of its bioactive compounds from traditional decoctions. Therefore, alternative extraction methods are required to enrich the active compounds and enhance their biological efficacy. The extract has been reported to protect against neuropathological conditions in brain cells and suppress oxidative stress and neuroinflammation-crucial for the initiation or progression of neurodegenerative diseases. Therefore, VA is a potential therapeutic agent for neurodegenerative diseases. However, the beneficial effects of VA on astrocytes, which are the predominant glial cells in the brain, remain unclear. In the present study, we investigated the protective effects of enzymatically digested VA extract (YC-1101) on the mitochondria in astrocytes, which are essential organelles regulating oxidative stress. Proteomic and metabolomic results using liquid chromatography-mass spectrometry (LC-MS/MS) identified enriched bioactive ingredients in YC-1101 compared to hot water extract of VA. YC-1101 displayed significant protective effects against mitochondrial stressors in astrocytes compared with other health functional ingredients. Altogether, our results showed improved bioactive efficacy of YC-1101 and its protective role against mitochondrial stressors in astrocytes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.